Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 11/20 | 0.79 |
| ▸ | MMP9 | P14780 | 10/20 | 0.79 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.74 |
| ▸ | MMP3 | P08254 | 2/20 | 0.70 |
| ▸ | MMP13 | P45452 | 2/20 | 0.70 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.70 |
| ▸ | MMP1 | P03956 | 1/20 | 0.70 |
| ▸ | MMP7 | P09237 | 1/20 | 0.70 |
| ▸ | CTSL | P07711 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1203540 | 1.00 | MMP2 (0.79) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| SCHEMBL697477 | 1.00 | MMP2 (0.79) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL11133046 | 0.99 | MMP2 (0.77) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3839410 | 0.99 | MMP2 (0.77) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28872216 | 0.97 | MMP2 (0.75) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| Chloromethane SCHEMBL7649372 | 0.97 | MMP2 (0.75) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| SCHEMBL3856155 | 0.96 | MMP2 (0.73) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| SCHEMBL561565 | 0.95 | MMP2 (0.71) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| SCHEMBL433897 | 0.95 | MMP2 (0.71) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| SCHEMBL8063645 | 0.94 | TDP1 (0.78) | MMP2MMP9ADAMTS4TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4330229-B1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2025-12-17 | — | — | EP | claimed |
| US-20240228437-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-07-11 | — | — | US | claimed |
| CN-117529470-A | Method for producing pyrrolidine compounds | 武田药品工业株式会社 | 2024-02-06 | — | — | CN | claimed |
| EP-0720657-B1 | BIOLOGICALLY RELEVANT METHODS FOR THE RAPID DETERMINATION OF STERILITY | 3M INNOVATIVE PROPERTIES CO (US) | 2007-08-15 | — | — | EP | claimed |
| EP-4330229-B1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2025-12-17 | — | — | EP | disclosed |
| EP-4494891-A1 | LAMINATE, CARD, PASSPORT, MANUFACTURING METHOD THEREOF, AND LASER MARKING METHOD | Mitsubishi Chemical Corporation (JP) | 2025-01-22 | — | — | EP | disclosed |
| US-20240399776-A1 | COLOR DEVELOPER, THERMAL RECORDING MATERIAL, AND THERMAL RECORDING LAYER COATING MATERIAL | SANKO CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| US-20240228437-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240228437-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-07-11 | — | — | US | disclosed |
| EP-4330229-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2024-03-06 | — | — | EP | disclosed |
| EP-4330229-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2024-03-06 | — | — | EP | disclosed |
| CN-117529470-A | Method for producing pyrrolidine compounds | 武田药品工业株式会社 | 2024-02-06 | — | — | CN | disclosed |
| US-5117031-A | ACTIVE ESTERS USED FOR PRODUCTION OF ESTERS OR AMIDES AND PROCESS FOR PRODUCING ESTERS OR AMIDES | SANSHIN KAGAKU KOGYO CO. LTD. (JP) | 1992-05-26 | — | — | US | disclosed |
| EP-0245662-B1 | P-HYDROXYPHENYLSULFONIUM SALTS AND THEIR USE IN THE PREPARATION OF ESTERS AND AMIDES | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1991-08-07 | — | — | EP | disclosed |
| US-4857656-A | Active esters used for production of esters or amides and process for producing esters or amides | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1989-08-15 | — | — | US | disclosed |
| EP-0245662-A1 | p-Hydroxyphenylsulfonium salts and their use in the preparation of esters and amides | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1987-11-19 | — | — | EP | disclosed |
| US-4670584-A | PHENYLALANINE DERIVATIVES FOR INSULIN AND OTHER DRUGS | AJINOMOTO COMPANY INCORPORATED (JP) | 1987-06-02 | — | — | US | disclosed |
| US-4650785-A | ORAL ADMINISTRATION OF INSULIN | AJINOMOTO COMPANY INCOPORATED (JP) | 1987-03-17 | — | — | US | disclosed |
| EP-0093551-A2 | Pharmaceutical composition | AJINOMOTO CO., INC. (JP) | 1983-11-09 | — | — | EP | disclosed |
| US-4072759-A | Novel benzylalcohol derivatives as antidiabetics and cardiotonics | TANABE SEIYAKU CO., LTD. (JA) | 1978-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228437-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | PAH, SPR, IL4I1 | MMP2 2034/4885MMP9 2916/4885ADAMTS4 4409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.